Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$194.44 - $217.61 $18,471 - $20,672
-95 Reduced 5.99%
1,491 $292,000
Q2 2023

Jul 25, 2023

SELL
$183.71 - $210.25 $89,099 - $101,971
-485 Reduced 23.42%
1,586 $333,000
Q1 2023

Apr 25, 2023

SELL
$191.89 - $259.92 $149,482 - $202,477
-779 Reduced 27.33%
2,071 $417,000
Q4 2022

Jan 26, 2023

SELL
$197.11 - $250.07 $633,708 - $803,975
-3,215 Reduced 53.01%
2,850 $0
Q3 2022

Oct 25, 2022

BUY
$182.44 - $250.54 $34,298 - $47,101
188 Added 3.2%
6,065 $1.19 Million
Q2 2022

Jul 26, 2022

SELL
$204.13 - $302.4 $148,402 - $219,844
-727 Reduced 11.01%
5,877 $1.26 Million
Q1 2022

Apr 26, 2022

BUY
$255.51 - $362.11 $25,039 - $35,486
98 Added 1.51%
6,604 $1.88 Million
Q4 2021

Jan 27, 2022

SELL
$351.38 - $448.68 $50,950 - $65,058
-145 Reduced 2.18%
6,506 $2.45 Million
Q3 2021

Oct 26, 2021

SELL
$372.64 - $458.3 $128,188 - $157,655
-344 Reduced 4.92%
6,651 $2.75 Million
Q2 2021

Jul 26, 2021

BUY
$294.17 - $371.65 $43,537 - $55,004
148 Added 2.16%
6,995 $2.59 Million
Q1 2021

Apr 22, 2021

BUY
$249.67 - $299.48 $144,808 - $173,698
580 Added 9.25%
6,847 $1.98 Million
Q4 2020

Jan 28, 2021

SELL
$222.0 - $252.62 $125,208 - $142,477
-564 Reduced 8.26%
6,267 $1.57 Million
Q3 2020

Oct 28, 2020

SELL
$175.56 - $226.45 $18,609 - $24,003
-106 Reduced 1.53%
6,831 $1.55 Million
Q2 2020

Jul 23, 2020

SELL
$118.84 - $189.72 $7,249 - $11,572
-61 Reduced 0.87%
6,937 $1.21 Million
Q1 2020

Apr 23, 2020

SELL
$98.9 - $178.34 $12,362 - $22,292
-125 Reduced 1.75%
6,998 $883,000
Q4 2019

Jan 30, 2020

SELL
$126.05 - $152.76 $29,495 - $35,745
-234 Reduced 3.18%
7,123 $1.09 Million
Q3 2019

Oct 24, 2019

BUY
$125.07 - $143.67 $920,139 - $1.06 Million
7,357 New
7,357 $974,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.7B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track First Merchants Corp Portfolio

Follow First Merchants Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Merchants Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Merchants Corp with notifications on news.